BackApellis Pharmaceuticals Overview

Apellis Pharmaceuticals Operating Income

Operating Income for APLS.

Quarterly Operating Income

$26.47M
↓ 131.76% YoY

As of Mar 31, 2026

Annual Operating Income (TTM)

$158.12M
↓ 169.65% YoY

Trailing 12 months ending Mar 31, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin